{"transactions":[{"id":3498,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-09-03T22:41:11.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":17557,"price":66.284,"value":1163748.188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $66.271 to $66.39. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":61003,"source":{"system":"sec-edgar","filing":"0001628280-26-060572","document":"wk-form4_1788475269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380710/000162828026060572/wk-form4_1788475269.xml","form_type":"4"}},{"id":833872,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:53:12.000Z","date":"2026-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":56.05,"value":71351.65,"ownership":{"direct":true},"balance_after":78560,"source":{"system":"sec-edgar","filing":"0001628280-26-019862","document":"wk-form4_1773953589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019862/wk-form4_1773953589.xml","form_type":"4"}},{"id":839168,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":34690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":34690,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-17","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":34690},"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":839167,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":14570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person's direct holdings have been adjusted by thirteen shares to correct a previous clerical error."}],"balance_after":79833,"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":839166,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:48:08.000Z","date":"2026-03-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7177,"price":58.51,"value":419926.27,"ownership":{"direct":true},"balance_after":65263,"source":{"system":"sec-edgar","filing":"0001628280-26-019010","document":"wk-form4_1773794885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019010/wk-form4_1773794885.xml","form_type":"4"}},{"id":880224,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-26","kind":"sale","planned":false,"acquired":false,"shares":26061,"price":61.36,"value":1599102.96,"ownership":{"direct":true},"balance_after":72453,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880223,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":2372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":98514,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880222,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":96142,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":880221,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-27T01:31:07.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":6177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2023 through 2025 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2026, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":89467,"source":{"system":"sec-edgar","filing":"0001628280-26-012533","document":"wk-form4_1772155864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026012533/wk-form4_1772155864.xml","form_type":"4"}},{"id":905767,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:52:06.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":83290,"source":{"system":"sec-edgar","filing":"0001628280-26-008216","document":"wk-form5_1771026723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008216/wk-form5_1771026723.xml","form_type":"5"}},{"id":1201349,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":30020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":30020,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":30020},"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1201348,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":12940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":82915,"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1201347,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:51:12.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":16249,"price":69.44,"value":1128330.56,"ownership":{"direct":true},"balance_after":69975,"source":{"system":"sec-edgar","filing":"0001048477-25-000037","document":"wk-form4_1742341865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000037/wk-form4_1742341865.xml","form_type":"4"}},{"id":1241455,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:15:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on core operating margin over three, one-year periods spanning 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":86224,"source":{"system":"sec-edgar","filing":"0001048477-25-000015","document":"wk-form4_1740701728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000015/wk-form4_1740701728.xml","form_type":"4"}},{"id":1241454,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:15:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":9660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of development goals achieved during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":76857,"source":{"system":"sec-edgar","filing":"0001048477-25-000015","document":"wk-form4_1740701728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000015/wk-form4_1740701728.xml","form_type":"4"}},{"id":1241453,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-28T00:15:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":11040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2022 through 2024 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2025, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":67197,"source":{"system":"sec-edgar","filing":"0001048477-25-000015","document":"wk-form4_1740701728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000015/wk-form4_1740701728.xml","form_type":"4"}},{"id":1498325,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-30T22:18:05.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":false,"shares":40850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":40850},"source":{"system":"sec-edgar","filing":"0001048477-24-000112","document":"wk-form4_1717107477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000112/wk-form4_1717107477.xml","form_type":"4"}},{"id":1498324,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-30T22:18:05.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":2779,"price":75.288,"value":209225.352,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $75.00 to $75.735. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":56157,"source":{"system":"sec-edgar","filing":"0001048477-24-000112","document":"wk-form4_1717107477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000112/wk-form4_1717107477.xml","form_type":"4"}},{"id":1498323,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-30T22:18:05.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":38071,"price":74.455,"value":2834576.305,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $74.12 to $74.99. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":58936,"source":{"system":"sec-edgar","filing":"0001048477-24-000112","document":"wk-form4_1717107477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000112/wk-form4_1717107477.xml","form_type":"4"}},{"id":1498322,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-30T22:18:05.000Z","date":"2024-05-28","kind":"exercise","planned":true,"acquired":true,"shares":40850,"price":63.1,"value":2577635.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."}],"balance_after":97007,"source":{"system":"sec-edgar","filing":"0001048477-24-000112","document":"wk-form4_1717107477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000112/wk-form4_1717107477.xml","form_type":"4"}},{"id":1526596,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-06T20:45:20.000Z","date":"2024-05-02","kind":"exercise","planned":true,"acquired":false,"shares":1850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":40850,"derivative":{"exercise_price":63.1,"exercise_date":"2014-12-04","expiration_date":"2024-06-30","underlying":"Common Stock","underlying_shares":1850},"source":{"system":"sec-edgar","filing":"0001048477-24-000075","document":"wk-form4_1715028307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000075/wk-form4_1715028307.xml","form_type":"4"}},{"id":1526595,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-06T20:45:20.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":1850,"price":85.01,"value":157268.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.00 to $85.03. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":56157,"source":{"system":"sec-edgar","filing":"0001048477-24-000075","document":"wk-form4_1715028307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000075/wk-form4_1715028307.xml","form_type":"4"}},{"id":1526594,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-06T20:45:20.000Z","date":"2024-05-02","kind":"exercise","planned":true,"acquired":true,"shares":1850,"price":63.1,"value":116735.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."}],"balance_after":58007,"source":{"system":"sec-edgar","filing":"0001048477-24-000075","document":"wk-form4_1715028307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000075/wk-form4_1715028307.xml","form_type":"4"}},{"id":1526593,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-06T20:45:20.000Z","date":"2024-04-30","kind":"grant","planned":true,"acquired":true,"shares":301,"price":68.646,"value":20662.446,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":56157,"source":{"system":"sec-edgar","filing":"0001048477-24-000075","document":"wk-form4_1715028307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000075/wk-form4_1715028307.xml","form_type":"4"}},{"id":1556790,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-04-01T20:54:11.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":24602,"price":88.34,"value":2173340.68,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."}],"balance_after":55856,"source":{"system":"sec-edgar","filing":"0001048477-24-000054","document":"wk-form4_1712004839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000054/wk-form4_1712004839.xml","form_type":"4"}},{"id":1570148,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T00:53:00.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":22990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter."}],"balance_after":22990,"derivative":{"exercise_price":83.87,"exercise_date":"2025-03-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":22990},"source":{"system":"sec-edgar","filing":"0001048477-24-000048","document":"wk-form4_1710895967.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000048/wk-form4_1710895967.xml","form_type":"4"}},{"id":1570147,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:53:00.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":21699,"price":83.87,"value":1819895.13,"ownership":{"direct":true},"balance_after":80458,"source":{"system":"sec-edgar","filing":"0001048477-24-000048","document":"wk-form4_1710895967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000048/wk-form4_1710895967.xml","form_type":"4"}},{"id":1570146,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:53:00.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":10260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 15, 2024. Price not applicable."}],"balance_after":102157,"source":{"system":"sec-edgar","filing":"0001048477-24-000048","document":"wk-form4_1710895967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000048/wk-form4_1710895967.xml","form_type":"4"}},{"id":1610643,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:16:51.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":6284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":91897,"source":{"system":"sec-edgar","filing":"0001048477-24-000026","document":"wk-form4_1709244996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000026/wk-form4_1709244996.xml","form_type":"4"}},{"id":1610642,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:16:51.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":9063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":85613,"source":{"system":"sec-edgar","filing":"0001048477-24-000026","document":"wk-form4_1709244996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000026/wk-form4_1709244996.xml","form_type":"4"}},{"id":1610641,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-29T22:16:51.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":20840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":76550,"source":{"system":"sec-edgar","filing":"0001048477-24-000026","document":"wk-form4_1709244996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000026/wk-form4_1709244996.xml","form_type":"4"}},{"id":1711292,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-12-14T23:18:21.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":13764,"price":95.3,"value":1311709.2,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2023."}],"balance_after":55710,"source":{"system":"sec-edgar","filing":"0001048477-23-000059","document":"wk-form4_1702595890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000059/wk-form4_1702595890.xml","form_type":"4"}},{"id":1812308,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-08-09T23:08:32.000Z","date":"2023-08-08","kind":"sale","planned":false,"acquired":false,"shares":11000,"price":89.4238,"value":983661.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The price actually received ranged from $89.39 to $89.52. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":69474,"source":{"system":"sec-edgar","filing":"0001048477-23-000033","document":"wk-form4_1691622498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000033/wk-form4_1691622498.xml","form_type":"4"}},{"id":1887302,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-05-18T21:19:46.000Z","date":"2023-05-16","kind":"gift","planned":false,"acquired":false,"shares":210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On May 16, 2023 the reporting person gifted 210 shares to an educational institution."}],"balance_after":80474,"source":{"system":"sec-edgar","filing":"0001209191-23-030719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030719/doc4.xml","form_type":"4"}},{"id":1887301,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-05-18T21:19:46.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":317,"price":66.88,"value":21200.96,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":80684,"source":{"system":"sec-edgar","filing":"0001209191-23-030719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123030719/doc4.xml","form_type":"4"}},{"id":1948003,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-03-18T01:31:58.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":20320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter."}],"balance_after":20320,"derivative":{"exercise_price":87.74,"exercise_date":"2024-03-15","expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":20320},"source":{"system":"sec-edgar","filing":"0001567619-23-005292","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005292/doc1.xml","form_type":"4"}},{"id":1948002,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:31:58.000Z","date":"2023-03-16","kind":"tax_withholding","acquired":false,"shares":19957,"price":93.41,"value":1864183.37,"ownership":{"direct":true},"balance_after":80367,"source":{"system":"sec-edgar","filing":"0001567619-23-005292","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005292/doc1.xml","form_type":"4"}},{"id":1948001,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:31:58.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":3025,"price":87.74,"value":265413.5,"ownership":{"direct":true},"balance_after":100324,"source":{"system":"sec-edgar","filing":"0001567619-23-005292","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005292/doc1.xml","form_type":"4"}},{"id":1948000,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-18T01:31:58.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":8900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2023. Price not applicable."}],"balance_after":103349,"source":{"system":"sec-edgar","filing":"0001567619-23-005292","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923005292/doc1.xml","form_type":"4"}},{"id":1980554,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:06.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":7424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":94449,"source":{"system":"sec-edgar","filing":"0001209191-23-014614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014614/doc4.xml","form_type":"4"}},{"id":1980553,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:06.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":10100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."}],"balance_after":87025,"source":{"system":"sec-edgar","filing":"0001209191-23-014614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014614/doc4.xml","form_type":"4"}},{"id":1980552,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:10:06.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2020 through 2022 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: vests on March 16, 2023, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":76925,"source":{"system":"sec-edgar","filing":"0001209191-23-014614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000120919123014614/doc4.xml","form_type":"4"}},{"id":1987866,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2023-03-01T02:22:57.000Z","date":"2023-02-24","kind":"exercise","acquired":false,"shares":1474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":1474},"source":{"system":"sec-edgar","filing":"0001567619-23-003998","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923003998/doc1.xml","form_type":"4"}},{"id":1987865,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-03-01T02:22:57.000Z","date":"2023-02-24","kind":"exercise","acquired":true,"shares":1474,"price":67.81,"value":99951.94,"ownership":{"direct":true},"balance_after":56725,"source":{"system":"sec-edgar","filing":"0001567619-23-003998","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761923003998/doc1.xml","form_type":"4"}},{"id":2188388,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-08-12T01:01:09.000Z","date":"2022-08-09","kind":"exercise","acquired":false,"shares":47526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":67.81,"exercise_date":"2013-11-15","expiration_date":"2023-05-14","underlying":"Common Stock","underlying_shares":47526},"source":{"system":"sec-edgar","filing":"0001567619-22-015635","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015635/doc1.xml","form_type":"4"}},{"id":2188387,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-08-12T01:01:09.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":47526,"price":95.93,"value":4559169.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price. The price actually received ranged from $95.540 to $96.400. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":55251,"source":{"system":"sec-edgar","filing":"0001567619-22-015635","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015635/doc1.xml","form_type":"4"}},{"id":2188386,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-08-12T01:01:09.000Z","date":"2022-08-09","kind":"exercise","acquired":true,"shares":47526,"price":67.81,"value":3222738.06,"ownership":{"direct":true},"balance_after":102777,"source":{"system":"sec-edgar","filing":"0001567619-22-015635","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015635/doc1.xml","form_type":"4"}},{"id":2188385,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-08-12T01:01:09.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":3690,"price":96.34,"value":355494.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price. The price actually received ranged from $96.310 to $96.425. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price."}],"balance_after":55251,"source":{"system":"sec-edgar","filing":"0001567619-22-015635","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922015635/doc1.xml","form_type":"4"}},{"id":2209301,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-07-11T23:46:22.000Z","date":"2022-07-08","kind":"sale","acquired":false,"shares":7398,"price":90,"value":665820.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 4, 2022."}],"balance_after":58941,"source":{"system":"sec-edgar","filing":"0001567619-22-013886","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922013886/doc1.xml","form_type":"4"}},{"id":2282713,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-05-04T16:01:01.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":15347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 4, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":15347},"source":{"system":"sec-edgar","filing":"0001567619-22-009494","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009494/doc1.xml","form_type":"4"}},{"id":2282712,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-05-04T16:01:01.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":15347,"price":80.38,"value":1233591.86,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 4, 2022."}],"balance_after":66339,"source":{"system":"sec-edgar","filing":"0001567619-22-009494","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009494/doc1.xml","form_type":"4"}},{"id":2282711,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-05-04T16:01:01.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":15347,"price":37.46,"value":574898.62,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 4, 2022."}],"balance_after":81686,"source":{"system":"sec-edgar","filing":"0001567619-22-009494","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009494/doc1.xml","form_type":"4"}},{"id":2282710,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-05-04T16:01:01.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":341,"price":62.407,"value":21280.787,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":66339,"source":{"system":"sec-edgar","filing":"0001567619-22-009494","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009494/doc1.xml","form_type":"4"}},{"id":2289844,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-04-28T00:40:35.000Z","date":"2022-04-25","kind":"exercise","acquired":false,"shares":2669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":37.46,"exercise_date":"2012-11-08","expiration_date":"2022-05-07","underlying":"Common Stock","underlying_shares":2669},"source":{"system":"sec-edgar","filing":"0001567619-22-009054","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009054/doc1.xml","form_type":"4"}},{"id":2289843,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-04-28T00:40:35.000Z","date":"2022-04-25","kind":"exercise","acquired":true,"shares":2669,"price":37.46,"value":99980.74,"ownership":{"direct":true},"balance_after":65998,"source":{"system":"sec-edgar","filing":"0001567619-22-009054","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922009054/doc1.xml","form_type":"4"}},{"id":2320337,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-24T01:16:19.000Z","date":"2022-03-21","kind":"sale","acquired":false,"shares":6129,"price":81.29,"value":498226.41,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 4, 2022."}],"balance_after":63329,"source":{"system":"sec-edgar","filing":"0001567619-22-007415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007415/doc1.xml","form_type":"4"}},{"id":2328538,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2022-03-18T01:24:19.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":26520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter."}],"balance_after":26520,"derivative":{"exercise_price":78.27,"exercise_date":"2023-03-15","expiration_date":"2032-03-14","underlying":"Common Stock","underlying_shares":26520},"source":{"system":"sec-edgar","filing":"0001567619-22-007181","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007181/doc1.xml","form_type":"4"}},{"id":2328537,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-18T01:24:19.000Z","date":"2022-03-16","kind":"tax_withholding","acquired":false,"shares":1252,"price":80.72,"value":101061.44,"ownership":{"direct":true},"balance_after":69458,"source":{"system":"sec-edgar","filing":"0001567619-22-007181","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007181/doc1.xml","form_type":"4"}},{"id":2328536,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-18T01:24:19.000Z","date":"2022-03-15","kind":"tax_withholding","acquired":false,"shares":8290,"price":78.27,"value":648858.3,"ownership":{"direct":true},"balance_after":70710,"source":{"system":"sec-edgar","filing":"0001567619-22-007181","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007181/doc1.xml","form_type":"4"}},{"id":2328535,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-18T01:24:19.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":11040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2022. Price not applicable."}],"balance_after":79000,"source":{"system":"sec-edgar","filing":"0001567619-22-007181","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922007181/doc1.xml","form_type":"4"}},{"id":2340265,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-03-10T22:28:35.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":9370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return for 2019 through 2021 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule:  100% vests on March 15, 2022, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events."}],"balance_after":67960,"source":{"system":"sec-edgar","filing":"0001567619-22-006716","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761922006716/doc1.xml","form_type":"4"}},{"id":2615589,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-08-04T20:59:14.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":5518,"price":76.69,"value":423175.42,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."}],"balance_after":58590,"source":{"system":"sec-edgar","filing":"0001567619-21-014415","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921014415/doc1.xml","form_type":"4"}},{"id":2730976,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-05-05T00:27:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2089,"price":78.3,"value":163568.7,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."}],"balance_after":64108,"source":{"system":"sec-edgar","filing":"0001567619-21-009021","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009021/doc1.xml","form_type":"4"}},{"id":2730975,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-05-05T00:27:42.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":2584,"price":78.3,"value":202327.2,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."}],"balance_after":66197,"source":{"system":"sec-edgar","filing":"0001567619-21-009021","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009021/doc1.xml","form_type":"4"}},{"id":2730974,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-05-05T00:27:42.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":341,"price":62.407,"value":21280.787,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":68781,"source":{"system":"sec-edgar","filing":"0001567619-21-009021","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921009021/doc1.xml","form_type":"4"}},{"id":2744209,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-04-21T01:53:18.000Z","date":"2021-04-19","kind":"exercise","acquired":false,"shares":2709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of options outstanding after the transactions from this specific stock option grant."}],"balance_after":0,"derivative":{"exercise_price":26.49,"exercise_date":"2011-11-12","expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":2709},"source":{"system":"sec-edgar","filing":"0001567619-21-008381","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008381/doc1.xml","form_type":"4"}},{"id":2744208,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-04-21T01:53:18.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":2709,"price":79.58,"value":215582.22,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."}],"balance_after":68440,"source":{"system":"sec-edgar","filing":"0001567619-21-008381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008381/doc1.xml","form_type":"4"}},{"id":2744207,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-04-21T01:53:18.000Z","date":"2021-04-19","kind":"exercise","acquired":true,"shares":2709,"price":26.49,"value":71761.41,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 12, 2021."}],"balance_after":71149,"source":{"system":"sec-edgar","filing":"0001567619-21-008381","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921008381/doc1.xml","form_type":"4"}},{"id":2775241,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-24T01:00:19.000Z","date":"2021-03-22","kind":"tax_withholding","acquired":false,"shares":1391,"price":78.52,"value":109221.32,"ownership":{"direct":true},"balance_after":68440,"source":{"system":"sec-edgar","filing":"0001567619-21-006818","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006818/doc1.xml","form_type":"4"}},{"id":2783475,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2021-03-18T01:35:16.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":25650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2022 and 1/48th on the 15th day of each month thereafter."}],"balance_after":25650,"derivative":{"exercise_price":78.39,"exercise_date":"2022-03-15","expiration_date":"2031-03-14","underlying":"Common Stock","underlying_shares":25650},"source":{"system":"sec-edgar","filing":"0001567619-21-006553","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006553/doc1.xml","form_type":"4"}},{"id":2783474,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-18T01:35:16.000Z","date":"2021-03-16","kind":"tax_withholding","acquired":false,"shares":1252,"price":77.21,"value":96666.92,"ownership":{"direct":true},"balance_after":69831,"source":{"system":"sec-edgar","filing":"0001567619-21-006553","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006553/doc1.xml","form_type":"4"}},{"id":2783473,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-18T01:35:16.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":5014,"price":78.39,"value":393047.46,"ownership":{"direct":true},"balance_after":71083,"source":{"system":"sec-edgar","filing":"0001567619-21-006553","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006553/doc1.xml","form_type":"4"}},{"id":2783472,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-18T01:35:16.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2021.  Price not applicable."}],"balance_after":76097,"source":{"system":"sec-edgar","filing":"0001567619-21-006553","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761921006553/doc1.xml","form_type":"4"}},{"id":3163971,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-05-05T01:45:16.000Z","date":"2020-05-01","kind":"sale","acquired":false,"shares":12504,"price":89.38,"value":1117607.52,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on March 27, 2020."}],"balance_after":65677,"source":{"system":"sec-edgar","filing":"0001567619-20-008957","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008957/doc1.xml","form_type":"4"}},{"id":3163970,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-05-05T01:45:16.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":339,"price":62.586,"value":21216.654,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":78181,"source":{"system":"sec-edgar","filing":"0001567619-20-008957","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920008957/doc1.xml","form_type":"4"}},{"id":3196813,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-25T00:53:50.000Z","date":"2020-03-20","kind":"tax_withholding","acquired":false,"shares":3309,"price":73.05,"value":241722.45,"ownership":{"direct":true},"balance_after":77842,"source":{"system":"sec-edgar","filing":"0001567619-20-006970","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006970/doc1.xml","form_type":"4"}},{"id":3206292,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2020-03-18T01:19:15.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":28790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter."}],"balance_after":28790,"derivative":{"exercise_price":73.82,"exercise_date":"2021-03-16","expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":28790},"source":{"system":"sec-edgar","filing":"0001567619-20-006634","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006634/doc1.xml","form_type":"4"}},{"id":3206291,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-18T01:19:15.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":10100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 16, 2020. Price not applicable."}],"balance_after":81151,"source":{"system":"sec-edgar","filing":"0001567619-20-006634","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006634/doc1.xml","form_type":"4"}},{"id":3206290,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-18T01:19:15.000Z","date":"2020-03-13","kind":"tax_withholding","acquired":false,"shares":7244,"price":84.5,"value":612118.0,"ownership":{"direct":true},"balance_after":71051,"source":{"system":"sec-edgar","filing":"0001567619-20-006634","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920006634/doc1.xml","form_type":"4"}},{"id":3228475,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2020-03-05T02:48:31.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":9586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events."}],"balance_after":78295,"source":{"system":"sec-edgar","filing":"0001567619-20-005679","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761920005679/doc1.xml","form_type":"4"}},{"id":3357883,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-11-27T23:47:09.000Z","date":"2019-11-26","kind":"sale","acquired":false,"shares":3190,"price":79.66,"value":254115.4,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 12, 2019."}],"balance_after":68709,"source":{"system":"sec-edgar","filing":"0001567619-19-022384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919022384/doc1.xml","form_type":"4"}},{"id":3497532,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-06-07T23:14:13.000Z","date":"2019-06-05","kind":"gift","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On June 5, 2019 the reporting person gifted 300 shares to an educational institution."}],"balance_after":71899,"source":{"system":"sec-edgar","filing":"0001567619-19-013107","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013107/doc1.xml","form_type":"4"}},{"id":3497531,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-06-07T23:14:13.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":309,"price":68.782,"value":21253.638,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2019, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":72199,"source":{"system":"sec-edgar","filing":"0001567619-19-013107","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919013107/doc1.xml","form_type":"4"}},{"id":3578955,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-27T00:01:55.000Z","date":"2019-03-25","kind":"sale","acquired":false,"shares":3363,"price":87.86,"value":295473.18,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 5, 2019."}],"balance_after":71890,"source":{"system":"sec-edgar","filing":"0001567619-19-007680","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007680/doc1.xml","form_type":"4"}},{"id":3578954,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-27T00:01:55.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":3309,"price":88.05,"value":291357.45,"ownership":{"direct":true},"balance_after":75253,"source":{"system":"sec-edgar","filing":"0001567619-19-007680","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007680/doc1.xml","form_type":"4"}},{"id":3583483,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-21T21:00:41.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":7907,"price":93.92,"value":742625.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on March 5, 2019."}],"balance_after":78562,"source":{"system":"sec-edgar","filing":"0001567619-19-007384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007384/doc1.xml","form_type":"4"}},{"id":3588383,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Stock Option (Right to buy Common Stock)","published_at":"2019-03-19T23:39:01.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":23450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2020 and 1/48th on the 15th day of each month thereafter."}],"balance_after":23450,"derivative":{"exercise_price":94.53,"exercise_date":"2020-03-15","expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":23450},"source":{"system":"sec-edgar","filing":"0001567619-19-007249","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007249/doc1.xml","form_type":"4"}},{"id":3588382,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-19T23:39:01.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":9370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on March 15, 2019. Price not applicable."}],"balance_after":86469,"source":{"system":"sec-edgar","filing":"0001567619-19-007249","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007249/doc1.xml","form_type":"4"}},{"id":3588381,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-19T23:39:01.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":6648,"price":94.53,"value":628435.44,"ownership":{"direct":true},"balance_after":77099,"source":{"system":"sec-edgar","filing":"0001567619-19-007249","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919007249/doc1.xml","form_type":"4"}},{"id":3614456,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-06T00:47:26.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":840,"price":94.76,"value":79598.4,"ownership":{"direct":true},"balance_after":83747,"source":{"system":"sec-edgar","filing":"0001567619-19-006236","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919006236/doc1.xml","form_type":"4"}},{"id":3614455,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2019-03-06T00:47:26.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":11853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events."}],"balance_after":84587,"source":{"system":"sec-edgar","filing":"0001567619-19-006236","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761919006236/doc1.xml","form_type":"4"}},{"id":3813240,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-09-18T20:42:22.000Z","date":"2018-09-14","kind":"sale","acquired":false,"shares":616,"price":99.456,"value":61264.896,"ownership":{"direct":true},"balance_after":72734,"source":{"system":"sec-edgar","filing":"0001567619-18-002824","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002824/doc1.xml","form_type":"4"}},{"id":3813239,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-09-18T20:42:22.000Z","date":"2018-09-14","kind":"sale","acquired":false,"shares":200,"price":99.455,"value":19891.0,"ownership":{"direct":true},"balance_after":73350,"source":{"system":"sec-edgar","filing":"0001567619-18-002824","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002824/doc1.xml","form_type":"4"}},{"id":3813238,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-09-18T20:42:22.000Z","date":"2018-09-14","kind":"sale","acquired":false,"shares":1400,"price":99.45,"value":139230.0,"ownership":{"direct":true},"balance_after":73550,"source":{"system":"sec-edgar","filing":"0001567619-18-002824","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002824/doc1.xml","form_type":"4"}},{"id":3814670,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-09-17T22:57:27.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":12000,"price":99.57,"value":1194840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the \"Common Stock\") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person contributed shares of common stock of BioMarin Pharmaceutical Inc. (the \"Common Stock\") to an exchange fund in exchange for shares of the exchange fund. The Common Stock was valued at $99.57 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person."}],"balance_after":74950,"source":{"system":"sec-edgar","filing":"0001567619-18-002760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000156761918002760/doc1.xml","form_type":"4"}},{"id":3903759,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-06-07T00:21:29.000Z","date":"2018-06-04","kind":"tax_withholding","acquired":false,"shares":1414,"price":92.07,"value":130186.98,"ownership":{"direct":true},"balance_after":86950,"source":{"system":"sec-edgar","filing":"0001140361-18-027607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027607/doc1.xml","form_type":"4"}},{"id":3903758,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-06-07T00:21:29.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":309,"price":68.782,"value":21253.638,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 79 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 13 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018."}],"balance_after":88364,"source":{"system":"sec-edgar","filing":"0001140361-18-027607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118027607/doc1.xml","form_type":"4"}},{"id":3955186,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-04-27T23:11:46.000Z","date":"2018-03-22","kind":"tax_withholding","acquired":false,"shares":3308,"price":81.36,"value":269138.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed solely to correct an administrative error in the original filing regarding the number of shares reported as forfeited."}],"balance_after":91326,"source":{"system":"sec-edgar","filing":"0001140361-18-020293","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118020293/doc1.xml","form_type":"4/A","original_submission_date":"2018-03-26"}},{"id":3956334,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-04-27T00:20:04.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":11601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements."},{"field":"shares","element":"transactionShares","label":"F3","text":"Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events."},{"field":"shares","element":"transactionShares","label":"F4","text":"This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned."}],"balance_after":94343,"source":{"system":"sec-edgar","filing":"0001140361-18-019851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118019851/doc1.xml","form_type":"4/A","original_submission_date":"2018-02-28"}},{"id":3982217,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":2405,"kind":"person","name":"Davis George Eric","position":1,"cik":"0001380710","reported_name":"Davis George Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, General Counsel"}}],"security":"Common Stock","published_at":"2018-03-27T22:17:45.000Z","date":"2018-03-23","kind":"sale","acquired":false,"shares":3350,"price":81.35,"value":272522.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on June 9, 2017."}],"balance_after":87989,"source":{"system":"sec-edgar","filing":"0001140361-18-015281","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000114036118015281/doc1.xml","form_type":"4"}}],"next_cursor":"2018-03-27T22:17:45.000000Z,3982217"}